This report comprises nine patients with DOCK8 deficiency, confirmed by bi-allelic DOCK8 variants by Sanger and/or exome sequencing, who received allogeneic HSCT after reduced toxicity conditioning at our institution between 2004 and 2017 (Table 1). The gene discussed is DOCK8; the disease is hyperinsulinemic hypoglycemia, familial, 4.